Publikationen, an denen er mitarbeitet Manuel José Morales González (2)

2022

  1. FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats

    Cells, Vol. 11, Núm. 9, pp. 1585

  2. Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment

    Biomedicines, Vol. 10, Núm. 6, pp. 1271